Duration of remission and long-term prognosis according to the extent of disease in patients with ulcerative colitis on continuous mesalamine treatment

Colorectal Disease

Volumn 10, Issue 8, 2008, Pages 814-817

  Bresci, G ^a   Parisi, G ^a   Capria, A ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MESALAZINE;

ADULT; ARTHRITIS; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; COLON RESECTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; DYSPEPSIA; ERYTHEMA NODOSUM; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RELAPSE; REMISSION; SACROILIITIS; ULCERATIVE COLITIS; UVEITIS;

ADMINISTRATION, ORAL; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLITIS, ULCERATIVE; COLONOSCOPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MESALAMINE; MIDDLE AGED; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; REMISSION INDUCTION; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 52949098748     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2008.01477.x     Document Type: Article

References (29)

1. Ritchie JK, Powell-Tuck J, Lennard-Jones JE. Clinical outcome of the first ten years of ulcerative colitis and proctitis. Lancet 1978; 1: 1140-3.
2. Michener WM, Farmer RG, Mortimer EA. Long-term prognosis of ulcerative colitis with onset in childhood or adolescence. J Clin Gastroenterol 1979; 1: 301-5.
3. Lanfranchi GA, Brignola C, Michelini M et al. Clinical course of ulcerative colitis in Italy. Digestion 1980; 20: 106-10.
4. Stonnington CM, Phillips SF, Zinsmeister AR, Melton LJ III. Prognosis of chronic ulcerative colitis in a community. Gut 1987; 28: 1261-6.
5. Bonstrom O, Monsen U, Nordenwall B, Sorstad J, Hellers G. Prognosis and mortality of ulcerative colitis in Stockholm County, 1955-1979. Scand J Gastroenterol 1987; 22: 907-13.
6. Softley A, Clamp SE, Watkinson G, Bouchier IA, Myren J, de Dombal FT. The natural history of inflammatory bowel disease: Has there been a change in the last 20years? Scand J Gastroenterol Suppl 1988; 144: 20-3.
7. Bonstrom O. Prognosis in ulcerative colitis. Med Clin North Am 1990; 74: 201-18.
8. Langholz E, Munkholm P, Davidsen M, Binder V. Long-term prognosis of patients with ulcerative colitis. Ugeskr Laeger 1993; 155: 3767-72.
9. Farmer RG, Easley KA, Rankin GB. Clinical patterns, natural history and progression of ulcerative colitis. A long-term follow-up of 1116 patients. Dig Dis Sci 1993; 38: 1137-46.
10. Langholz E, Munkholm P, Davidsen M, Binder V. Course of ulcerative colitis: Analysis of changes in disease activity over years. Gastroenterology 1994; 107 (1): 3-11.
11. Selby W. The natural history of ulcerative colitis. Baillieres Clin Gastroenterol 1997; 11: 53-64.
12. Bresci G, Parisi G, Gambardella L, Banti S, Bertoni M, Rindi G et al. Evaluation of clinical patterns in ulcerative colitis. A long term follow-up. Int J Pharm Res 1997; 1: 17-22.
13. Kaminaga M, Satake Y. Long-term prognosis of ulcerative colitis. Nippon Rinsho 1999; 57: 2437-42.
14. Katoh H, Iwane S, Munakata A, Nakaji S, Sugawara K. Long-term prognosis of patients with ulcerative colitis in Japan. J Epidemiol 2000; 10: 48-54.
15. Misiewicz J, Lennard-jones JE, Connell AM, Baron JH, Jones FA. Controlled trial of sulphasalazine in maintenance therapy in ulcerative colitis. Lancet 1965; 1: 185-8.
16. Riis P, Anthonisen P, Wulff HR, Folkenborg O, Bonnevie O, Binder V. The prophylactic effect of salazosulphapyridine in ulcerative colitis during long-term treatment. A double-blind trial on patients asymptomatic for one year. Scand J Gastroentrol 1973; 8: 71-4.
17. Azad Khan AK, Piris J, Truelove SC. An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet 1977; 2: 892-5.
18. Ardizzone S, Petrillo M, Molteni P, Desideri S, Bianchi Porro G. Coated oral 5-aminosalicylic acid (Claversal) is equivalent to sulfasalazine for remission maintenance in ulcerative coltis. J Clin Gastroenterol 1995; 21: 287-8.
19. Sutherland L, May G, Shaffer E. Sulfasalazine revised: A meta-analisys of 5-aminosalicylic acid in the treatment of ulcerative colitis. Ann Intern Med 1993; 118: 540-9.
20. Trallori G, d'Albasio G, Bardazzi G, Bonanomi AG, Amorosi A, Del Carlo P et al. 5-aminosalicylic acid in pregnancy: Clinical report. Ital J Gastroenterol 1994; 26: 75-8.
21. Miner P, Hanauer S, Robinson M, Schwartz J, Arora S, Pentasa Maintenance Study Group. Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Dig Dis Sci 1995; 40: 296-304.
22. The Mesalamine Study Group. An oral preparation of mesalamine as long-term maintenance therapy for ulcerative colitis. A randomized, placebo-controlled trial. Ann Intern Med 1996; 124: 204-11.
23. Ardizzone S, Petrillo M, Imbesi V, Cerutti R, Bollani S, Bianchi Porro G. Is mantenance therapy always necessary for patients with ulcerative colitis in remission? Aliment Pharmacol Ther 1999; 13: 373-9.
24. Paoluzzi OA, Iacopini F, Pera A, Bianchi Porro G, Pica R et al. Oral and topical 5-aminosalicylic acid (mesalazine) in inducing and mantaining remission in mild-moderate relapse of ulcerative colitis: One-year randomised multicentre trial. Digest Liver Dis 2002; 34: 787-93.
25. Baker DE, Kane S. The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis. Rev Gastroenterol Disord 2004; 4: 86-91.
26. Bedd JR, Scott BB. How effective are the usual treatments for ulcerative colitis? Aliment Pharmacol Ther 2004; 20: 1143-9.
27. Paoluzzi P, Iacopini F, Pica R, Crispino P, Marcheggiano A, Consolazio A et al. Comparison of two different daily dosages (2.4 vs 1.2g) of oral mesalazine in maintenance of remission in ulcerative colitis patients: 1-year follow up study. Aliment Pharmacol Ther 2005; 21: 1111-9.
28. Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on therapeutic trial. Br Med J 1955; 2: 1041-8.
29. Powell-Tuck J, Day DW, Buck NA, Wadsworth J, Lennard-Jones JE. Correlation between defined sigmoidscopic appearances and other measures of disease activity in ulcerative colitis. Dig Dis Sci 1982; 27: 533-7.